A possible case of maculopapular eruption associated with glecaprevir/pibrentasvir treatment for chronic hepatitis C virus infection. Issue 4 (31st March 2021)

• Record Type: Journal Article
• Authors: Tomiyasu, Hiroka; Nakajima, Saeko; Kaku, Yo; Hirata, Masahiro; Kataoka, Tatsuki; Nomura, Takashi; Kabashima, Kenji
• Is Part Of: Journal of cutaneous immunology and allergy. Volume 4:Issue 4(2021)
• Page Start: 92
• Page End: 94
• Publication Date: 2021-03-31
• Subjects: Skin -- Diseases -- Immunological aspects -- Periodicals; Skin -- Diseases -- Periodicals; Skin -- Diseases -- Treatment -- Periodicals; 616.5079
• DOI: 10.1002/cia2.12166
• Languages: English
• ISSNs: 2574-4593

Abstract

Abstract : Tomiyasu et al. report a possible case of maculopapular eruption associated with G/P treatment. Based upon the clinical course and histological analysis, the present case may be mediated by allergic mechanism. Since G/P treatment is widely used because of its efficacy and safety, clinical dermatologists should be aware that G/P may cause cutaneous drug eruption mediated by allergic responses.